Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- SELF-MEDICATION NEWS IN BRIEF
March 20, 2006
- Shionogi, Galderma Announce Marketing Alliance for Acne Treatment
March 20, 2006
- Micrus Obtains Approval for Its Endovascular Treatment System
March 20, 2006
- Kyorin Switches to Holding Company System
March 20, 2006
- Imatron Japan's Heart Laser Recommended for Approval
March 20, 2006
- Asahi Kasei Aims to Boost Pharma Business to \160 Bil. in FY2010
March 20, 2006
- MEDICAL DEVICE NEWS IN BRIEF
March 20, 2006
- BUSINESS NEWS IN BRIEF
March 20, 2006
- Patients"Opinions Should Be Reflected in Evaluation of Generics: Prof. Yanagawa
March 20, 2006
- Kyowa Hakko Completes PIII Trials of Parkinson's Treatment KW-6002
March 20, 2006
- JammNet Publishes Generic Market Share Report for 2005
March 20, 2006
- Kyorin Starts PI Study of New Diabetes Treatment in the US
March 20, 2006
- JMA to Hold 27th General Assembly April 5-8 in Osaka
March 20, 2006
- New Drug Applications Declined in 2005: OPIR Survey
March 20, 2006
- Use of Anti-allergy Drugs by GPs Surveyed by JMDC
March 20, 2006
- Slow Clinical Trials Delaying Domestic Launch of New Drugs
March 20, 2006
- New NHI Prices Announced: Anti-ulcer Drugs See 10.5% Price Cut
March 20, 2006
- PMDA to Provide More Consultations by Streamlining Its Operation
March 20, 2006
- Sanofi-aventis Readying for Launch of Plavix
March 20, 2006
- Public Symposium Focuses on Cancer Diagnosis and Treatment
March 20, 2006
ページ
Japan’s pharmaceutical policy appears to be entering a new phase. The government’s newly approved honebuto policy and growth strategy both…
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…